Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H38O2 |
| Molecular Weight | 382.5787 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C=C(CC[C@]4(C)[C@H]3CC[C@]12C)OC5CCCC5
InChI
InChIKey=XAVRSHOUEXATJE-FBQZJRKBSA-N
InChI=1S/C26H38O2/c1-17(27)22-10-11-23-21-9-8-18-16-20(28-19-6-4-5-7-19)12-14-25(18,2)24(21)13-15-26(22,23)3/h8,16,19,21-24H,4-7,9-15H2,1-3H3/t21-,22+,23-,24-,25-,26+/m0/s1
| Molecular Formula | C26H38O2 |
| Molecular Weight | 382.5787 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Quingestrone is a progestin, or a synthetic progestogen, patented by Laboratoires francais de chimiotherapie as an anti-inflammatory agent. Quingestrone acts as an agonist of the progesterone receptor weak glucocorticoid activity. Quingestrone was formerly used in combination with ethinylestradiol or mestranol in combined birth control pills in Italy. The medication was studied in the clinical prevention of miscarriage during pregnancy, but insufficient efficacy was observed at the dosage assessed
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5340429
100 mg/day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:50:11 GMT 2025
by
admin
on
Mon Mar 31 17:50:11 GMT 2025
|
| Record UNII |
0612VZ9I5Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C389
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
||
|
NCI_THESAURUS |
C776
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
67-95-8
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
SUB10217MIG
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
C005621
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
Quingestrone
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
100000080279
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
1525
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104568
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
C152126
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
DTXSID00217196
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
9929903
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY | |||
|
0612VZ9I5Z
Created by
admin on Mon Mar 31 17:50:11 GMT 2025 , Edited by admin on Mon Mar 31 17:50:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |